Ryan et al (18) demonstrated that the degree of survivin expression correlated with tumor progression, the degree of malignancy and pathology classification, and that survivin may be used in relation to breast cancer diagnosis and in indicating prognosis. This evidence concerns the gene BIRC5 and neoplasm.